Sandoval Boburg Rodrigo, Kondov Stoyan, Karamitev Mladen, Schlensak Christian, Berger Rafal, Haeberle Helene, Jost Walter, Fagu Albi, Beyersdorf Friedhelm, Kreibich Maximilian, Czerny Martin, Siepe Matthias
Department of Thoracic and Cardiovascular Surgery, University Hospital Tübingen, 72076 Tübingen, Germany.
Department of Cardiovascular Surgery, University Heart Center Freiburg-Bad Krozingen, 79106 Freiburg, Germany.
J Cardiovasc Dev Dis. 2023 Oct 30;10(11):446. doi: 10.3390/jcdd10110446.
The aim of this study was to analyze outcomes in patients undergoing surgery for ventricular septal rupture (VSR) after myocardial infarction (MI) and the preoperative use of extracorporeal life support (ECLS) as a bridge to surgery.
We included patients undergoing surgery for VSR from January 2009 until June 2021 from two centers in Germany. Patients were separated into two groups, those with and without ECLS, before surgery. Pre- and intraoperative data, outcome, and survival during follow-up were evaluated.
A total of 47 consecutive patients were included. Twenty-five patients were in the ECLS group, and 22 were in the group without ECLS. All the ECLS-group patients were in cardiogenic shock preoperatively. Most patients in the ECLS group were transferred from another hospital [n = 21 (84%) vs. no-ECLS (n = 12 (57.1%), = 0.05]. We observed a higher number of postoperative bleeding complications favoring the group without ECLS [n = 6 (28.6%) vs. n = 16 (64%), < 0.05]. There was no significant difference in the persistence of residual ventricular septal defect (VSD) between groups [ECLS n = 4 (16.7%) and no-ECLS n = 3 (13.6%)], = 1.0. Total in-hospital mortality was 38.3%. There was no significant difference in in-hospital mortality [n = 6 (27.3%) vs. n = 12 (48%), = 0.11] and survival at last follow-up between the groups ( = 0.50).
We detected no statistical difference in the in-hospital and long-term mortality in patients who received ECLS as supportive therapy after MI-induced VSR compared to those without ECLS. ECLS could be an effective procedure applied as a bridge to surgery in patients with VSR and cardiogenic shock.
本研究旨在分析心肌梗死(MI)后室间隔破裂(VSR)接受手术治疗患者的预后,以及术前使用体外生命支持(ECLS)作为手术桥梁的情况。
我们纳入了2009年1月至2021年6月期间来自德国两个中心接受VSR手术的患者。术前将患者分为两组,即使用ECLS组和未使用ECLS组。评估术前和术中数据、预后以及随访期间的生存率。
共纳入47例连续患者。ECLS组25例,未使用ECLS组22例。所有ECLS组患者术前均处于心源性休克状态。ECLS组大多数患者从另一家医院转诊而来[n = 21(84%),未使用ECLS组为n = 12(57.1%),P = 0.05]。我们观察到未使用ECLS组术后出血并发症更多[n = 6(28.6%)对n = 16(64%),P < 0.05]。两组间残余室间隔缺损(VSD)持续存在情况无显著差异[ECLS组n = 4(16.7%),未使用ECLS组n = 3(13.6%)],P = 1.0。院内总死亡率为38.3%。两组间院内死亡率[n = 6(27.3%)对n = 12(48%),P = 0.11]及末次随访时的生存率无显著差异(P = 0.50)。
我们发现,与未使用ECLS的患者相比,MI后VSR接受ECLS作为支持治疗的患者在院内和长期死亡率方面无统计学差异。ECLS可作为VSR合并心源性休克患者手术的有效桥梁手段。